Literature DB >> 17169838

Muc4 expression during blood vessel formation in damaged rat cornea.

Jin Zhang1, Coralie A Carothers Carraway, Kermit L Carraway.   

Abstract

PURPOSE: To determine the timing of Muc4 expression during the association of endothelial cells to form blood vessels in the rat corneal stroma after corneal wounding.
METHODS: Corneal damage was inflicted using brief cauterization with silver nitrite. Contralateral and wounded corneas were examined at time periods after wounding by immunohistochemistry and immunofluorescence for Muc4 and for the blood vessel endothelial cell marker von Willebrand Factor.
RESULTS: Blood vessels and von Willebrand Factor-stained cells were very sparse in corneal stroma from unwounded corneas. In contrast, aggregates of von Willebrand Factor-stained cells were prevalent in wounded corneas at days 4-5 and 7-10. Muc4 expression was limited at days 4-5, but extensive at days 7-10.
CONCLUSION: Muc4 expression develops in endothelial cells during the mid-stages of cell aggregation and blood vessel formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169838     DOI: 10.1080/02713680601052155

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.

Authors:  Heather C Workman; Jamie K Miller; Ellen Q Ingalla; Rouminder P Kaur; Diane I Yamamoto; Laurel A Beckett; Lawrence Jt Young; Robert D Cardiff; Alexander D Borowsky; Kermit L Carraway; Colleen Sweeney; Kermit L Carraway
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

2.  Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.

Authors:  A R Rowson-Hodel; J H Wald; J Hatakeyama; W K O'Neal; J R Stonebraker; K VanderVorst; M J Saldana; A D Borowsky; C Sweeney; K L Carraway
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.